An Open-Label, Comparative, Multicentre Study of Peginterferon Alfa-2a ( 40kd) Plus Ribavirin in the Treatment of Patients Chronically Infected with Hcv/Hbv or Hcv Alone

臨床醫學研究所LIU, CHUN-JENCHUN-JENLIUCHUANG, WAN-LONGWAN-LONGCHUANGLEE, CHUAN-MOCHUAN-MOLEEWU, SHUN-SHENGSHUN-SHENGWULIAO, LI-YINGLI-YINGLIAOKUO, HSING-TAOHSING-TAOKUOCHAO, YOU-CHENYOU-CHENCHAOCHEN, CHI-LINGCHI-LINGCHENCHEN, PEI-JERPEI-JERCHENCHEN, DING-SHINNDING-SHINNCHEN2009-12-242018-07-062009-12-242018-07-062008http://ntur.lib.ntu.edu.tw//handle/246246/175455en-USAn Open-Label, Comparative, Multicentre Study of Peginterferon Alfa-2a ( 40kd) Plus Ribavirin in the Treatment of Patients Chronically Infected with Hcv/Hbv or Hcv Alone